Sema4D/PlexinB1 inhibition ameliorates blood-brain barrier damage and improves outcome after stroke in rats.
Zhou YF, Li YN, Jin HJ, Wu JH, He QW, Wang XX, Lei H, Hu B.
Zhou YF, et al. Among authors: lei h.
FASEB J. 2018 Apr;32(4):2181-2196. doi: 10.1096/fj.201700786RR. Epub 2018 Jan 5.
FASEB J. 2018.
PMID: 29242274
Our study indicates that Sema4D may be a novel therapeutic target for treatment in the acute phase of stroke.-Zhou, Y.-F., Li, Y.-N., Jin, H.-J., Wu, J.-H., He, Q.-W., Wang, X.-X., Lei, H., Hu, B. Sema4D/PlexinB1 inhibition ameliorates blood-brain barr …
Our study indicates that Sema4D may be a novel therapeutic target for treatment in the acute phase of stroke.-Zhou, Y.-F., Li, Y.-N., Jin, …